Skip to main content

Advertisement

SpringerLink
Log in

The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal Chemotherapy

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

ABSTRACT

Background

Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) are complex surgeries with multiple comorbidities. The Clavien–Dindo classification (CDC) is the most commonly used method to report surgical morbidity, but limits it to the highest-grade complication. The Comprehensive Complication Index (CCI) is a score ranging from 0 to 100, calculated using all 30-day complications and their treatment after abdominal surgery. The aim of this study is to assess the CCI’s validity in the HIPEC patient population.

Methods

A review of our institutional cytoreduction database from 2009 to 2015 was undertaken. Patient demographics, pathology, Peritoneal Carcinomatosis Index (PCI), complications and their treatments, and length of stay (LOS) were reviewed. The CCI was calculated for each patient. Linear regression was used to assess whether the CCI and CDC were predictors of LOS.

Results

Of 157 patients reviewed, 110 (70.1%) underwent HIPEC. The majority were female (77, 66.9%), and the mean age was 53.7 years. Mean PCI was 13.2 [interquartile range (IQR) 7–18]. Median CDC was grade 2 (IQR 0–2), and only 9.8% had CDC of grade 4 or higher. Mean CCI was 21.4, while the median was 20.9 (IQR 0–30.8). Mean LOS was 16.2 days, while the median was 11 days (IQR 8–15 days). The CCI strongly correlated with LOS with coefficient of 0.46 [95% confidence interval (CI) 0.38–0.54, p = 0.000].

Conclusions

The CCI is an adequate tool to capture all complications and their overall burden in patients having undergone HIPEC. This study shows that the CCI can predict LOS and could be used to quantify and compare the burden of multiple complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009; 249: 900–907.

    Article  PubMed  Google Scholar 

  2. Clavien PA, Barkun J, de Oliveira ML et al. The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250: 187–196.

    Article  PubMed  Google Scholar 

  3. Clavien PA, Strasberg SM. Severity grading of surgical complications. Ann Surg. 2009; 250: 197–198.

    Article  PubMed  Google Scholar 

  4. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240: 205–213.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lehmann K, Eshmuminov D, Slankamenac K et al. Where oncologic and surgical complication scoring systems collide: time for a new consensus for CRS/HIPEC. World J Surg. 2016; 40: 1075–1081.

    Article  PubMed  Google Scholar 

  6. Winship C MR. Regression models with ordinal variables. Am Sociol Rev. 1984; 49: 13.

    Article  Google Scholar 

  7. Slankamenac K, Graf R, Barkun J et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013; 258: 1–7.

    Article  PubMed  Google Scholar 

  8. Slankamenac K, Nederlof N, Pessaux P et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014; 260: 757–762; discussion 762–753.

  9. Slaman AE, Lagarde SM, Gisbertz SS, van Berge Henegouwen MI. A quantified scoring system for postoperative complication severity compared to the Clavien–Dindo classification. Dig Surg. 2015; 32: 361–366.

    Article  PubMed  Google Scholar 

  10. Nederlof N, Slaman AE, van Hagen P et al. Using the comprehensive complication index to assess the impact of neoadjuvant chemoradiotherapy on complication severity after esophagectomy for cancer. Ann Surg Oncol. 2016, 23(12):3964–3971.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Marsman EM, de Rooij T, van Eijck CH et al. Pancreatoduodenectomy with colon resection for cancer: a nationwide retrospective analysis. Surgery. 2016; 160: 145–152.

    Article  PubMed  Google Scholar 

  12. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996; 82: 359–374.

    Article  CAS  PubMed  Google Scholar 

  13. Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005; 2: 3.

    Article  PubMed  PubMed Central  Google Scholar 

  14. AssesSurgery. In. http://www.assessurgery.com/calculator_single.

  15. Burnham KP, Anderson DR. Multimodel inference: understanding AIC and BIC in model selection. Sociol Methods Res. 2004; 33: 261.

    Article  Google Scholar 

  16. Jafari MD, Halabi WJ, Stamos MJ, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the American College of Surgeons National Surgical Quality Improvement Program. JAMA Surg. 2014; 149: 170–175.

    Article  PubMed  Google Scholar 

  17. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010; 28: 63–68.

    Article  PubMed  Google Scholar 

  18. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009; 27: 681–685.

    Article  PubMed  Google Scholar 

  19. Yan TD, Deraco M, Baratti D et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009; 27: 6237–6242.

    Article  PubMed  Google Scholar 

  20. Martin RC, 2nd, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg. 2002; 235: 803–813.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003; 13: 176–181.

    Article  PubMed  Google Scholar 

  22. Younan R, Kusamura S, Baratti D et al. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 2008; 98: 253–257.

    Article  PubMed  Google Scholar 

  23. Basch E, Jia X, Heller G et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J Natl Cancer Inst. 2009; 101: 1624–1632.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chow A, Mayer EK, Darzi AW, Athanasiou T. Patient-reported outcome measures: the importance of patient satisfaction in surgery. Surgery 2009; 146: 435–443.

    Article  PubMed  Google Scholar 

  25. Strasberg SM, Hall BL. Postoperative morbidity index: a quantitative measure of severity of postoperative complications. J Am Coll Surg 2011; 213: 616–626.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Sinziana Dumitra is recipient of the Shiabata Fellowship, awarded by the Cedar Cancer Foundation, Montreal, Canada.

Author information

Authors and Affiliations

  1. Department of Surgery, City of Hope, Duarte, CA, USA

    Sinziana Dumitra MD, MSc, Michael O’Leary MD, Mustafa Raoof MD, Mark Wakabayashi MD, Thanh H. Dellinger MD, Ernest S. Han MD, Stephen J. Lee MD & Byrne Lee MD

Authors
  1. Sinziana Dumitra MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael O’Leary MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mustafa Raoof MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark Wakabayashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thanh H. Dellinger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ernest S. Han MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephen J. Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Byrne Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sinziana Dumitra MD, MSc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dumitra, S., O’Leary, M., Raoof, M. et al. The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 25, 688–693 (2018). https://doi.org/10.1245/s10434-017-6157-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-6157-z

Keywords

Search

Navigation